Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.66 |
| ▸ | MEN1 | O00255 | 2/20 | 0.66 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.64 |
| ▸ | NPC1 | O15118 | 3/20 | 0.64 |
| ▸ | RAB9A | P51151 | 3/20 | 0.64 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | TMEM97 | Q5BJF2 | 3/20 | 0.51 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.51 |
| ▸ | GRIN2B | Q13224 | 3/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | GRM5 | P41594 | 2/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL467515 | 0.94 | MEN1 (0.59) | KMT2AMEN1NPSR1SMN1; SMN2NPC1 | |
| SCHEMBL3614455 | 0.93 | MEN1 (0.58) | KMT2AMEN1NPSR1SMN1; SMN2NPC1 | |
| SCHEMBL3602428 | 0.91 | MEN1 (0.62) | KMT2AMEN1NPSR1SMN1; SMN2NPC1 | |
| SCHEMBL265902 | 0.91 | MEN1 (0.58) | KMT2AMEN1NPSR1SMN1; SMN2NPC1 | |
| Hydrochloric Acid SCHEMBL9207633 | 0.89 | MEN1 (0.54) | KMT2AMEN1NPSR1SMN1; SMN2NPC1 | |
| SCHEMBL4814264 | 0.88 | MEN1 (0.76) | KMT2AMEN1NPSR1SMN1; SMN2NPC1 | |
| SCHEMBL7393652 | 0.88 | MEN1 (0.76) | KMT2AMEN1NPSR1SMN1; SMN2NPC1 | |
| SCHEMBL3970912 | 0.88 | MEN1 (0.76) | KMT2AMEN1NPSR1SMN1; SMN2NPC1 | |
| SCHEMBL379160 | 0.88 | MEN1 (0.76) | KMT2AMEN1NPSR1SMN1; SMN2NPC1 | |
| SCHEMBL3612576 | 0.88 | MEN1 (0.59) | KMT2AMEN1NPSR1SMN1; SMN2NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2835 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1934561-B1 | IMPROVED TIME/TEMPERATURE INDICATORS | SUN CHEMICAL CORP (US) | 2018-11-07 | — | — | EP | claimed |
| US-20080269050-A1 | Time/Temperature Indicators | SUN CHEMICAL CORPORATION (US) | 2008-10-30 | — | — | US | claimed |
| EP-1934561-A1 | IMPROVED TIME/TEMPERATURE INDICATORS | Sun Chemical Corporation (US) | 2008-06-25 | — | — | EP | claimed |
| WO-2007035365-A1 | IMPROVED TIME/TEMPERATURE INDICATORS | SUN CHEMICAL CORPORATION (US) | 2007-03-29 | — | — | WO | claimed |
| WO-2006091465-A1 | TIME/TEMPERATURE INDICATORS, THEIR PREPARATION AND USE | SUN CHEMICAL CORPORATION (US) | 2006-08-31 | — | — | WO | claimed |
| US-4477669-A | Processes and intermediates useful in the preparation of flutroline | PFIZER INC. (US) | 1984-10-16 | — | — | US | claimed |
| EP-0082658-A2 | Processes and intermediates useful in the preparation of flutroline | PFIZER INC. (US) | 1983-06-29 | — | — | EP | claimed |
| EP-4747253-A1 | SPIROCYCLIC WRN HELICASE INHIBITORS | Merck Sharp & Dohme LLC (US) | 2026-05-27 | — | — | EP | disclosed |
| EP-4027995-B1 | HPK1 ANTAGONISTS AND USES THEREOF | NIMBUS SATURN INC (US) | 2026-05-27 | — | — | EP | disclosed |
| WO-2026103730-A1 | DIAZAHETEROCYCLIC DERIVATIVE OF PYRIDOARYL GROUP HAVING KAPPA RECEPTOR ANTAGONISTIC ACTIVITY AND COMPOSITION THEREOF, AND USE | 江苏恩华药业股份有限公司 | 2026-05-21 | — | — | WO | disclosed |
| EP-4199925-B1 | CYCLOPENTAPYRROLE OREXIN RECEPTOR AGONISTS | MERCK SHARP & DOHME LLC (US) | 2026-05-20 | — | — | EP | disclosed |
| CN-122070277-A | Androgen receptor PROTAC | 葛兰素史密斯克莱知识产权发展有限公司 | 2026-05-19 | — | — | CN | disclosed |
| CN-122070148-A | Inhibitors of targeted fibroblast activation proteins | 苏州博锐创合医药有限公司 | 2026-05-19 | — | — | CN | disclosed |
| EP-0082658-A2 | Processes and intermediates useful in the preparation of flutroline | PFIZER INC. (US) | 1983-06-29 | — | — | EP | disclosed |
| US-4353901-A | HYPERTENSION, CONGESTIVE HEART FAILURE, ARRHYTHMIAMIGRAINE, VASOSPASTIC DISORDERS, ASTHMA | SYNTEX (U.S.A.) INC. (US) | 1982-10-12 | — | — | US | disclosed |
| US-4353900-A | HYPOTENSIVE, ANTIARRHYTHMIA, CARDIOTONIC, VASODILATORS | SYNTEX (U.S.A.) INC. (US) | 1982-10-12 | — | — | US | disclosed |
| EP-0061333-A1 | 9-(2-(3-Indolyl)ethyl)-1-oxa-4,9-diazaspiro(5.5)undecan-3-ones | SYNTEX (U.S.A.) INC. (US) | 1982-09-29 | — | — | EP | disclosed |
| US-4332804-A | TREATMENT OF HYPERTENSION, CONGESTIVE HEART FAILURE, ARRHYTHMIA, MIGRAINE, VASOSPASTIC DISORDERS AND ASTHMA | SYNTEX (U.S.A.) INC. (US) | 1982-06-01 | — | — | US | disclosed |
| US-4255432-A | ANTIHYPERTENSIVE AGENTS, ANTIHISTAMINES, BRONCHODILATOR AGENTS, ANTIVASOSPASTIC AGENTS | SYNTEX (U.S.A.) INC. (US) | 1981-03-10 | — | — | US | disclosed |
| US-4244961-A | 1-Oxa-3,8-diazaspiro[4.5]decan-2-ones antihypertensive agents | SYNTEX (U.S.A.) INC. (US) | 1981-01-13 | — | — | US | disclosed |